CyGene Laboratories Offers StrokeScan Genetic Screening


July 22, 2008

CyGene's StrokeScan is a genetic screening test aimed at identifying high risk individuals who have a family history of stroke, cardiovascular or kidney disease.

StrokeScan analyzes genes that have been associated with the increased risk of stroke and the “alpha-galactosidase A” gene that is responsible for Fabry disease. Fabry disease is a genetic disorder that results in an enzyme deficiency that commonly causes death before age 55 by way of stroke, heart attack or kidney failure.

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.